MedPath

IMIQUIMOD 5% / LEVOCETIRIZINE DIHYDROCHLORIDE 1% / TRETINOIN 0.05%

IMIQUIMOD 5% / LEVOCETIRIZINE DIHYDROCHLORIDE 1% / TRETINOIN 0.05%

Approved
Approval ID

87395273-37fb-7cef-e053-2991aa0a54c6

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Apr 23, 2019

Manufacturers
FDA

Sincerus Florida, LLC

DUNS: 080105003

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

IMIQUIMOD 5% / LEVOCETIRIZINE DIHYDROCHLORIDE 1% / TRETINOIN 0.05%

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code72934-1126
Product Classification
G
Generic Name
IMIQUIMOD 5% / LEVOCETIRIZINE DIHYDROCHLORIDE 1% / TRETINOIN 0.05%
Product Specifications
Route of AdministrationTOPICAL
Effective DateApril 23, 2019
FDA Product Classification

INGREDIENTS (3)

TRETINOINActive
Quantity: 0.05 g in 100 g
Code: 5688UTC01R
Classification: ACTIB
LEVOCETIRIZINE DIHYDROCHLORIDEActive
Quantity: 1 g in 100 g
Code: SOD6A38AGA
Classification: ACTIB
IMIQUIMODActive
Quantity: 5 g in 100 g
Code: P1QW714R7M
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

IMIQUIMOD 5% / LEVOCETIRIZINE DIHYDROCHLORIDE 1% / TRETINOIN 0.05% - FDA Drug Approval Details